Assignee
CYTOVIA THERAPEUTICS LLC
US·0 granted patents·2 pending applications·0 citations·filing 2022–2022
Top patents by PatentIndex Score
2 records- 0158US2024199759A1Bispecific antibodies targeting nkp46 and gpc3 and methods of use thereofCYTOVIA THERAPEUTICS LLC·Filed 2022·Application pending·0 cites
- 0258US2024199756A1Bispecific antibodies targeting nkp46 and cd38 and methods of use thereofCYTOVIA THERAPEUTICS LLC·Filed 2022·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when CYTOVIA THERAPEUTICS LLC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →